Aktie 002198 GUANGDONG JIAYING PHARMACEUTICAL CO., LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Guangdong Jiaying Pharmaceutical Co., Ltd

Aktien

002198

CNE1000008P1

002198

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 26.04.2024 		% 5 Tage % 1. Jan.
6.47 CNY -4.43% Intraday Chart für Guangdong Jiaying Pharmaceutical Co., Ltd -2.85% -11.13%
26.04. Guangdong Jiaying Pharmaceutical Co., Ltd berichtet über die Ergebnisse für das erste Quartal zum 31. März 2024 CI
26.04. Guangdong Jiaying Pharmaceutical Co., Ltd berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Announcement of Resolutions of Guangdong Jiaying?s Fifth Extraordinary General Meeting of Shareholders in 2021
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Guangdong Jiaying Pharmaceutical Co., Ltd. Approves Management Appointments
Resolutions on Supervisor Nomination by Guangdong Jiaying Venture Capital
Guangdong Jiaying Venture Capital Submits Proposals Related to Supervisor Nominations
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Guangzhou Taiping Enterprise Management Partnership (Limited Partnership) signed the Share Transfer Agreement to acquire 5% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Shaobin for approximately CNY 195 million.
Jiaying Pharma Sees Up to 3,420% Surge in 2022 Profit
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
Jiaying Pharmaceutical’s Profit Crashes 93% in 2021 Despite Revenue Growth
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
Liu Libiao completed the acquisition of 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Huang Zhiyong and Huang Libing.
Chen Shaobin completed the acquisition of 10% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Yonghong.
Liu Libiao agreed to acquire 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Huang Zhiyong and Huang Libing for approximately CNY 210 million.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 002198 Aktie
  4. Nachrichten Guangdong Jiaying Pharmaceutical Co., Ltd
  5. Andere Sprachen